Vaxcyte, Inc. Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vaxcyte, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vaxcyte, Inc. for April 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 23 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | M | 1.79 | 2,793 | 4,999 | 88,836 | |
Apr 23 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Buy | M | 1.79 | 2,793 | 4,999 | 4,201 | 1.4 K to 4.2 K (+198.37 %) |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | J | 2.03 | 7,611 | 15,450 | 22,027 | |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | J | 2.03 | 7,611 | 15,450 | 22,027 | |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | J | 2.03 | 21,871 | 44,398 | 48,197 | |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | J | 2.03 | 21,871 | 44,398 | 48,197 | |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | J | 1.79 | 14,253 | 25,513 | 7,173 | |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | J | 1.79 | 14,253 | 25,513 | 7,173 | |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | J | 0.80 | 4,168 | 3,334 | 4,168 | |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | J | 0.80 | 4,168 | 3,334 | 4,168 | |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Sell | J | 0.00 | 38,308 | 0 | 39,591 | 77.9 K to 39.6 K (-49.18 %) |
Apr 07 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Sell | J | 0.00 | 38,308 | 0 | 39,591 | 77.9 K to 39.6 K (-49.18 %) |
Apr 06 2021 | PCVX | Vaxcyte, Inc. | Fairman Jeff | VP, Research | Option Exercise | A | 20.93 | 40,000 | 837,200 | 40,000 | |
Apr 06 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Option Exercise | A | 20.93 | 93,340 | 1,953,606 | 93,340 | |
Apr 06 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | A | 20.93 | 40,000 | 837,200 | 40,000 | |
Apr 06 2021 | PCVX | Vaxcyte, Inc. | Wassil Jim | Chief Operating Off ... | Option Exercise | A | 20.93 | 93,340 | 1,953,606 | 93,340 | |
Apr 06 2021 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | President and CFO | Option Exercise | A | 20.93 | 145,000 | 3,034,850 | 145,000 | |
Apr 06 2021 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | Chief Executive Off ... | Option Exercise | A | 20.93 | 310,000 | 6,488,300 | 310,000 |